alexa Defining And Managing A Corporate Quality Culture | 20400
ISSN: 2329-6631

Journal of Developing Drugs
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Summit on GMP, GCP & Quality Control

David L Chesney
Keynote: J Dev Drugs
DOI: 10.4172/2329-6631.S1.005
Abstract
Defining and Managing a Corporate Quality Culture Commonly, companies who face regulatory compliance problems decide that ?The culture needs to change? but few know what has contributed to their problems, or how to bring about the needed changes. This presentation will discuss the factors that often cause companies to face difficulties in establishing a corporate culture that supports quality and GMP compliance, and also the steps that a company can take to develop a strong, supportive culture of quality. The discussion will include: ? Five common factors that contribute to corporate quality culture problems ? Five steps that can be taken to promote a positive corporate quality culture ? A ?prescription? for positive quality culture change
Biography
David L Chesney, Vice President and Practice Lead, Strategic Compliance Services for PAREXEL Consulting, works with PAREXEL clients in the pharmaceutical, biologics and medical device industries worldwide. He also directs PAREXEL Consulting?s Strategic Compliance Services group. Prior to joining PAREXEL Consulting, he served 23 years with the FDA. Chesney advanced from Investigator to Supervisory Investigator and Director, Investigations Branch, working in the Boston, Seattle and Philadelphia District Offices. In 1991, he was appointed the District Director, San Francisco District Office, where he served until joining PAREXEL in 1995. His expertise includes GMP, GCP, GLP, QSR and MDR compliance consulting and auditing. Chesney is highly experienced in the FDA enforcement process and specializes in helping clients avoid or mitigate enforcement sanctions. He has extensive experience providing adjunct services to client legal counsel, including FDA communication strategies, conduct of internal investigations, due diligence assessments and other privileged matters. Recently Chesney has completed corporate quality organization effectiveness assessments for major pharmaceutical companies, biotech companies, and virtual companies. Chesney frequently conducts briefing and training sessions for senior managers and executives in compliance topics and FDA inspection readiness. He is an experienced public speaker and has published articles in several industry publications such as Pharmaceutical Technoology, Biopharm, RAPS Focus, and FDLI Update. He has authored or co-authored two book chapters, one in the current FDLI Practical Guide to Working with the Food and Drug Administration, and another on application of GMP to the production of investigational medicinal products. He has taught PDA TRI courses in inspection readiness and quality and compliance management for virtual companies. Chesney received his BA in Biology from California State University, Northridge. He subsequently completed postgraduate study in biology there and at California State University, San Diego, and has also received a Certificate in Health Care Compliance from Seton Hall University School of Law. He is an active member of the Parenteral Drug Association where he serves on the faculty of the PDA Training and Research Institute (TRI), the Food and Drug Law Institute (where he serves as a member of the Drugs and Biologics Committee), and the Regulatory Affairs Professionals Society.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]csonline.com

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7